Health Technology Assessment in Pharmaceutical Reimbursement Policy in Kazakhstan

The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries.

OBJECTIVE Middle-income countries are often referred to as developing or emerging economies and face multiple challenges of severe financial stresses in their health care sectors, and high disease burden. The objective of this study is to provide an overview of how health technology assessment (HTA) is used and organized in selected middle-income countries and its role in the process of pharmac...

Mentoring a health technology assessment initiative in Kazakhstan.

OBJECTIVES The aim of this study was to assist in the development of a health technology assessment (HTA) program for the Ministry of Health (MOH) of the Republic of Kazakhstan METHODS Mentoring of an initial HTA program in Kazakhstan was provided by the Canadian Society for International Health (CSIH) by means of a partnership with the Kazakhstan MOH. HTA materials, courses, and one-on-one s...

Variation in Health Technology Assessment and Reimbursement Processes in Europe.

BACKGROUND It has been suggested that differences in health technology assessment (HTA) processes among countries, particularly within Europe, have led to inequity in patient access to new medicines. OBJECTIVES To provide an up-to-date snapshot analysis of the present status of HTA and reimbursement systems in select European countries, and to investigate the implications of these processes, ...

[Health technology assessment and its impact on pharmaceutical pricing and reimbursement policies].

The article conceptualizes the pharmaceutical pricing and reimbursement policies related to financial coverage in the context of health systems. It introduces the pharmaceutical market as an imperfect one, in which appropriate regulation is required. Moreover, the basis that guide the pricing and reimbursement processes are defined and described in order to generate a categorization based on wh...

Health Technology Assessment and Health Policy-making in Europe